Immune reconstitution syndromes in human immuno-deficiency virus infection following effective antiretroviral therapy

Immunobiology. 2000 Aug;202(2):186-93. doi: 10.1016/S0171-2985(00)80065-0.

Abstract

Effective antiretroviral therapy leads to rapid decrease in plasma HIV-1 RNA, frequently followed by an increase in CD4 T-helper cell counts. The improvement of immune function during highly active antiretroviral therapy has important impact on natural history of AIDS-related opportunistic disorders. Here we describe cases of unusual clinical inflammatory syndromes in CMV retinitis, hepatitis C, and atypical mycobacteriosis in HIV-1 infected patients associated with the initiation of antiretroviral therapy. Pathogenetic implications and therapeutic management of these new immunopathologic syndromes are discussed.

Publication types

  • Case Reports

MeSH terms

  • AIDS-Related Opportunistic Infections / complications
  • AIDS-Related Opportunistic Infections / drug therapy
  • AIDS-Related Opportunistic Infections / immunology*
  • AIDS-Related Opportunistic Infections / virology
  • Acquired Immunodeficiency Syndrome / drug therapy
  • Acquired Immunodeficiency Syndrome / immunology*
  • Acquired Immunodeficiency Syndrome / virology
  • Adult
  • Anti-HIV Agents / therapeutic use*
  • Antiretroviral Therapy, Highly Active*
  • Cytomegalovirus Retinitis / complications
  • Cytomegalovirus Retinitis / immunology*
  • Female
  • HIV Protease Inhibitors / therapeutic use
  • HIV-1 / genetics
  • HIV-1 / immunology*
  • Hepatitis C / complications
  • Hepatitis C / immunology*
  • Humans
  • Indinavir / therapeutic use
  • Lamivudine / therapeutic use
  • Male
  • Middle Aged
  • Mycobacterium avium-intracellulare Infection / complications
  • Mycobacterium avium-intracellulare Infection / immunology*
  • Reverse Transcriptase Inhibitors / therapeutic use
  • Zidovudine / therapeutic use

Substances

  • Anti-HIV Agents
  • HIV Protease Inhibitors
  • Reverse Transcriptase Inhibitors
  • Lamivudine
  • Zidovudine
  • Indinavir